ALPHANATE (antihemophilic factor, human/von Willebrand factor,human)
ANTIHEMOPHILIC PRODUCTS·HEMOPHILIA A·+6
GRIFOLS
Indication
Acquired factor VIII deficiency disease
Acquired factor VIII deficiency disease, also known as acquired hemophilia A, is a rare autoimmune bleeding disorder characterized by the spontaneous development of neutralizing autoantibodies directed against endogenous coagulation factor VIII. Read more about Acquired factor VIII deficiency disease
7 drugs 5 manufacturers
Drugs that treat it
Common Acquired factor VIII deficiency disease therapies.
OCTAPHARMA USA
CSL BEHRING, LL
WILATE (antihemophilic factor, human/von Willebrand factor,human)
ANTIHEMOPHILIC PRODUCTS·HEMOPHILIA A·+6
OCTAPHARMA USA
CSL BEHRING, LL
OCTAPHARMA USA
HUMATE-P (antihemophilic factor, human/von Willebrand factor,human)
ANTIHEMOPHILIC PRODUCTS·HEMOPHILIA A·+6
CSL Behring
Filter & compare in the drug finder →Opens the drug finder with Acquired factor VIII deficiency disease preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcquired factor VIII deficiency disease, also known as acquired hemophilia A, is a rare autoimmune bleeding disorder characterized by the spontaneous development of neutralizing autoantibodies directed against endogenous coagulation factor VIII.
This condition affects the hematologic and vascular systems in individuals without a personal or hereditary history of coagulopathy, occurring most frequently in older adults of either sex and occasionally in the postpartum setting or in association with underlying autoimmune diseases or malignancies.
Pathophysiologically, the antibody-mediated neutralization or clearance of factor VIII disrupts the intrinsic coagulation pathway, manifesting clinically as sudden, often severe or life-threatening mucocutaneous hemorrhage, extensive subcutaneous ecchymoses, deep soft-tissue or intramuscular hematomas, and prolonged activated partial thromboplastin time that fails to correct with normal plasma.
- nih.gov
Acquired factor VIII deficiency disease, also known as acquired hemophilia A, is a rare autoimmune bleeding disorder characterized by the spontaneous development of neutralizing autoantibodies directed against endogenous coagulation factor VIII
- nih.gov
Acquired factor VIII deficiency disease, also known as acquired hemophilia A, is a rare autoimmune bleeding disorder characterized by the spontaneous development of neutralizing autoantibodies directed against endogenous coagulation factor VIII
- nih.gov
This condition affects the hematologic and vascular systems in individuals without a personal or hereditary history of coagulopathy, occurring most frequently in older adults of either sex and occasionally in the postpartum setting or in association with underlying autoimmune diseases or malignancies Pathophysiologically, the antibody-mediated neutralization or clearance of factor VIII disrupts the intrinsic coagulation pathway, manifesting clinically as sudden, often severe or life-threatening ...
- nih.gov
This condition affects the hematologic and vascular systems in individuals without a personal or hereditary history of coagulopathy, occurring most frequently in older adults of either sex and occasionally in the postpartum setting or in association with underlying autoimmune diseases or malignancies Pathophysiologically, the antibody-mediated neutralization or clearance of factor VIII disrupts the intrinsic coagulation pathway, manifesting clinically as sudden, often severe or life-threatening ...
- haemophilia.org.au
This condition affects the hematologic and vascular systems in individuals without a personal or hereditary history of coagulopathy, occurring most frequently in older adults of either sex and occasionally in the postpartum setting or in association with underlying autoimmune diseases or malignancies
- nih.gov
Pathophysiologically, the antibody-mediated neutralization or clearance of factor VIII disrupts the intrinsic coagulation pathway, manifesting clinically as sudden, often severe or life-threatening mucocutaneous hemorrhage, extensive subcutaneous ecchymoses, deep soft-tissue or intramuscular hematomas, and prolonged activated partial thromboplastin time that fails to correct with normal plasma
Personalize your experience
Follow Acquired factor VIII deficiency disease and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.